Skip to main content
SpringerLink
Log in

Toxoplasmosis

  • Chapter
Intraocular Inflammation

Abstract

Toxoplasmosis is caused by Toxoplasma gondii, an obligate intracellular protozoan which parasites the majority of warm-blooded animals worldwide. Human systemic infection is usually minor and self-limited, but may have serious consequences especially in immunocompromised individuals and in fetuses after vertical transmission. Toxoplasmosis is also the leading cause of posterior uveitis in many countries.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 299.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 379.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Aggio FB, Muccioli C, Belfort R Jr (2006) Intravitreal triamcinolone acetonide as an adjunct in the treatment of severe ocular toxoplasmosis. Eye 20:1080–1082

    Article  CAS  PubMed  Google Scholar 

  2. Akstein RB, Wilson LA, Teutsch SM (1982) Acquired toxoplasmosis. Ophthalmology 89:1299–1302

    Article  CAS  PubMed  Google Scholar 

  3. Alexander J, Hunter CA (1998) Immunoregulation during toxoplasmosis. Chem Immunol 70:81–102

    Article  CAS  PubMed  Google Scholar 

  4. Alvarenga DP, Couto MF, Pessoa VF (2007) Perceptual visual filling-in of toxoplasmic retinochoroiditis scotomas. Neuroreport 18:1679–1681

    Article  PubMed  Google Scholar 

  5. Alves CF, Vitor RW (2005) Efficacy of atovaquone and sulfadiazine in the treatment of mice infected with Toxoplasma gondii strains isolated in Brazil. Parasite 12:171–177

    Article  CAS  PubMed  Google Scholar 

  6. Amaro MH, Muccioli C, Abreu MT et al (2007) Remote hypofluorescent dots in recurrent ocular toxoplasmosis on indocyanine green angiography. Arq Bras Oftalmol 70:901–904

    Article  PubMed  Google Scholar 

  7. Antinori A, Larussa D, Cingolani A et al (2004) Prevalence, associated factors, and prognostic determinants of AIDS-related toxoplasmic encephalitis in the era of advanced highly active antiretroviral therapy. Clin Infect Dis 39:1681–1691

    Article  PubMed  Google Scholar 

  8. Araujo FG, Remington JS (1987) Toxoplasmosis in immunocompromised patients. Eur J Clin Microbiol 6:1–2

    Article  CAS  PubMed  Google Scholar 

  9. Auer C, Bernasconi O, Herbort CP (1999) Indocyanine green angiography features in toxoplasmic retinochoroiditis. Retina 19:22–29

    Article  CAS  PubMed  Google Scholar 

  10. Bahia MD, Oréfice F, Andrade GMQ (1992) Clinical analysis of retinochoroiditis’ lesions in children bearing congenital toxoplasmosis. Rev Bras Oftalmol 51:13–19

    Google Scholar 

  11. Bahia-Oliveira LM, Jones JL, Azevedo-Silva J et al (2003) Highly endemic, waterborne toxoplasmosis in north Rio de Janeiro state, Brazil. Emerg Infect Dis 9:55–62

    Article  PubMed Central  PubMed  Google Scholar 

  12. Bhopale GM (2003) Pathogenesis of toxoplasmosis. Comp Immunol Microbiol Infect Dis 26:213–222

    Article  CAS  PubMed  Google Scholar 

  13. Bohne W, Holpert M, Gross U (1999) Stage differentiation of the protozoan parasite Toxoplasma gondii. Immunobiology 201:248–254

    Article  CAS  PubMed  Google Scholar 

  14. Bonfioli AA, Oréfice F (2005) Toxoplasmosis. Semin Ophthalmol 20:129–141

    Article  PubMed  Google Scholar 

  15. Bosch-Driessen LE, Berendschot TT, Ongkosuwito JV et al (2002) Ocular toxoplasmosis: clinical features and prognosis of 154 patients. Ophthalmology 109:869–878

    Article  PubMed  Google Scholar 

  16. Bosch-Driessen LH, Plaisier MB, Stilma JS et al (2002) Reactivations of ocular toxoplasmosis after cataract extraction. Ophthalmology 109:41–45

    Article  PubMed  Google Scholar 

  17. Bosch-Driessen EH, Rothova A (1999) Recurrent ocular disease in postnatally acquired toxoplasmosis. Am J Ophthalmol 128:421–425

    Article  CAS  PubMed  Google Scholar 

  18. Bou G, Figueroa MS, Marti-Belda P et al (1999) Value of PCR for detection of Toxoplasma gondii in aqueous humor and blood samples from immunocompetent patients with ocular toxoplasmosis. J Clin Microbiol 37:3465–3468

    PubMed Central  CAS  PubMed  Google Scholar 

  19. Bowie WR, King AS, Werker DH et al (1997) Outbreak of toxoplasmosis associated with municipal drinking water. The BC Toxoplasma Investigation Team. Lancet 350:173–177

    Article  CAS  PubMed  Google Scholar 

  20. Brenier-Pinchart MP, Pelloux H, Derouich-Guergour D et al (2001) Chemokines in host-protozoan-parasite interactions. Trends Parasitol 17:292–296

    Article  CAS  PubMed  Google Scholar 

  21. Burnett AJ, Shortt SG, Isaac-Renton J et al (1998) Multiple cases of acquired toxoplasmosis retinitis presenting in an outbreak. Ophthalmology 105:1032–1037

    Article  CAS  PubMed  Google Scholar 

  22. Buzoni-Gatel D, Kasper LH (2007) Innate immunity in Toxoplasma gondii infection. In: Weiss LM, Kim K (eds) Toxoplasma gondii – the model apicomplexan: perspectives and methods. Elsevier Academic Press, Amsterdam, pp 593–607

    Chapter  Google Scholar 

  23. Cohen BA (1999) Neurologic manifestations of toxoplasmosis in AIDS. Semin Neurol 19:201–211

    Article  CAS  PubMed  Google Scholar 

  24. Cook AJ, Gilbert RE, Buffolano W et al (2000) Sources of toxoplasma infection in pregnant women: European multicentre case-control study. European Research Network on Congenital Toxoplasmosis. BMJ 321:142–147

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  25. Cordeiro CA, Moreira PR, Andrade MS et al (2008) Interleukin-10 gene polymorphism (-1082a/g) is associated with toxoplasmic retinochoroiditis. Invest Ophthalmol Vis Sci 49:1979–1982

    Article  PubMed  Google Scholar 

  26. Costa RA, Skaf M, Melo LA Jr et al (2006) Retinal assessment using optical coherence tomography. Prog Retin Eye Res 25:325–353

    Article  PubMed  Google Scholar 

  27. Couvreur J, Thulliez P (1996) Acquired toxoplasmosis of ocular or neurologic site: 49 cases. Presse Med 25:438–442

    CAS  PubMed  Google Scholar 

  28. da Mata AP, Oréfice F (2002) Toxoplasmosis. In: Foster CS, Vitale AT (eds) Diagnosis and treatment of uveitis. WB Saunders, Philadelphia, pp 385–140

    Google Scholar 

  29. Dao A, Fortier B, Soete M et al (2001) Successful reinfection of chronically infected mice by a different Toxoplasma gondii genotype. Int J Parasitol 31:63–65

    Article  CAS  PubMed  Google Scholar 

  30. de Moura L, Bahia-Oliveira LM, Wada MY et al (2006) Waterborne toxoplasmosis, Brazil, from field to gene. Emerg Infect Dis 12:326–329

    Article  PubMed Central  PubMed  Google Scholar 

  31. Demar M, Ajzenberg D, Maubon D et al (2007) Fatal outbreak of human toxoplasmosis along the Maroni River: epidemiological, clinical, and parasitological aspects. Clin Infect Dis 45:e88–e95

    Article  PubMed  Google Scholar 

  32. Desmonts G (1966) Definitive serological diagnosis of ocular toxoplasmosis. Arch Ophthalmol 76:839–851

    Article  CAS  PubMed  Google Scholar 

  33. Dobbie JG (1968) Cryotherapy in the management of toxoplasma retinochoroiditis. Trans Am Acad Ophthalmol Otolaryngol 72:364–373

    CAS  PubMed  Google Scholar 

  34. Dobbin CA, Smith NC, Johnson AM (2002) Heat shock protein 70 is a potential virulence factor in murine toxoplasma infection via immunomodulation of host NF-kappa B and nitric oxide. J Immunol 169:958–965

    Article  CAS  PubMed  Google Scholar 

  35. Dubey JP (2007) The history and life cycle of Toxoplasma gondii. In: Weiss LM, Kim K (eds) Toxoplasma gondii – the model apicomplexan: perspectives and methods. Elsevier Academic Press, Amsterdam, pp 1–17

    Chapter  Google Scholar 

  36. Dunn D, Wallon M, Peyron F et al (1999) Mother-to-child transmission of toxoplasmosis: risk estimates for clinical counselling. Lancet 353:1829–1833

    Article  CAS  PubMed  Google Scholar 

  37. Eyles DE, Coleman N (1953) Antibiotics in the treatment of toxoplasmosis. Am J Trop Med Hyg 2:64–69

    CAS  PubMed  Google Scholar 

  38. Fardeau C, Romand S, Rao NA et al (2002) Diagnosis of toxoplasmic retinochoroiditis with atypical clinical features. Am J Ophthalmol 134:196–203

    Article  PubMed  Google Scholar 

  39. Fernandes LC, Oréfice F (1996) Clinical and epidemiological aspects of uveitis in reference services in Belo Horizonte between 1970 and 1993: part II. Rev Bras Oftalmol 55:579–592

    Google Scholar 

  40. Ferreira AM, Vitor RW, Gazzinelli RT et al (2006) Genetic analysis of natural recombinant Brazilian Toxoplasma gondii strains by multilocus PCR-RFLP. Infect Genet Evol 6:22–31

    Article  CAS  Google Scholar 

  41. Filisetti D, Candolfi E (2004) Immune response to Toxoplasma gondii. Ann Ist Super Sanita 40:71–80

    CAS  PubMed  Google Scholar 

  42. Fiona R, Mets MB, Ferguson DJ et al (2001) Histopathological features of ocular toxoplasmosis in the fetus and infant. Arch Ophtalmol 119:51–58

    Google Scholar 

  43. Garweg JG (2005) Determinants of immunodiagnostic success in human ocular toxoplasmosis. Parasite Immunol 27:61–68

    Article  CAS  PubMed  Google Scholar 

  44. Gazzinelli RT, Hakim FT, Hieny S et al (1991) Synergistic role of CD4+ and CD8+ T lymphocytes in IFN-gamma production and protective immunity induced by an attenuated Toxoplasma gondii vaccine. J Immunol 146:286–292

    CAS  PubMed  Google Scholar 

  45. Ghartey KN, Brockhurst RJ (1980) Photocoagulation of active toxoplasmic retinochoroiditis. Am J Ophthalmol 89:858–864

    Article  CAS  PubMed  Google Scholar 

  46. Gilbert R, Gras L (2003) Effect of timing and type of treatment on the risk of mother to child transmission of Toxoplasma gondii. BJOG 110:112–120

    Article  CAS  PubMed  Google Scholar 

  47. Gilbert RE, Stanford MR (2000) Is ocular toxoplasmosis caused by prenatal or postnatal infection? Br J Ophthalmol 84:224–226

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  48. Goncalves RM, Rodrigues DH, Camargos da Costa AM et al (2007) Increased serum levels of CXCL8 chemokine in acute toxoplasmic retinochoroiditis. Acta Ophthalmol Scand 85:871–876

    Article  CAS  PubMed  Google Scholar 

  49. Gras L, Wallon M, Pollak A et al (2005) Association between prenatal treatment and clinical manifestations of congenital toxoplasmosis in infancy: a cohort study in 13 European centres. Acta Paediatr 94:1721–1731

    Article  PubMed  Google Scholar 

  50. Grigg ME, Ganatra J, Boothroyd JC et al (2001) Unusual abundance of atypical strains associated with human ocular toxoplasmosis. J Infect Dis 184:633–639

    Article  CAS  PubMed  Google Scholar 

  51. Hegab SM, Al-Mutawa SA (2003) Immunopathogenesis of toxoplasmosis. Clin Exp Med 3:84–105

    Article  CAS  PubMed  Google Scholar 

  52. Henderly DE, Genstler AJ, Smith RE et al (1987) Changing patterns of uveitis. Am J Ophthalmol 103:131–136

    Article  CAS  PubMed  Google Scholar 

  53. Hercos BV, Muinos SJ, Casaroli-Marano RP (2004) Utility of ultrasonography in toxoplasmic uveitis. Arch Soc Esp Oftalmol 79:59–65

    PubMed  Google Scholar 

  54. Hogan MJ (1958) Ocular Toxoplasmosis: XIV Edward Jackson memorial lecture. Am J Ophthalmol 46:467–494

    Article  CAS  PubMed  Google Scholar 

  55. Hogan MJ, Kimura SJ, Lewis A et al (1957) Early and delayed ocular manifestations of congenital toxoplasmosis. Trans Am Ophthalmol Soc 55:275–293; discussion 293–276

    PubMed Central  PubMed  Google Scholar 

  56. Holland GN (2003) Ocular toxoplasmosis: a global reassessment. Part I: epidemiology and course of disease. Am J Ophthalmol 136:973–988

    Article  PubMed  Google Scholar 

  57. Holland GN (2004) Ocular toxoplasmosis: a global reassessment. Part II: disease manifestations and management. Am J Ophthalmol 137:1–17

    PubMed  Google Scholar 

  58. Holland GN, Lewis KG (2002) An update on current practices in the management of ocular toxoplasmosis. Am J Ophthalmol 134:102–114

    Article  PubMed  Google Scholar 

  59. Holland GN, Muccioli C, Silveira C et al (1999) Intraocular inflammatory reactions without focal necrotizing retinochoroiditis in patients with acquired systemic toxoplasmosis. Am J Ophthalmol 128:413–420

    Article  CAS  PubMed  Google Scholar 

  60. Howe DK, Sibley LD (1995) Toxoplasma gondii comprises three clonal lineages: correlation of parasite genotype with human disease. J Infect Dis 172:1561–1566

    Article  CAS  PubMed  Google Scholar 

  61. Johnson MW, Greven GM, Jaffe GJ et al (1997) Atypical, severe toxoplasmic retinochoroiditis in elderly patients. Ophthalmology 104:48–57

    Article  CAS  PubMed  Google Scholar 

  62. Johnson LL, Sayles PC (1997) Interleukin-12, dendritic cells, and the initiation of host-protective mechanisms against Toxoplasma gondii. J Exp Med 186:1799–1802

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  63. Jones LA, Alexander J, Roberts CW (2006) Ocular toxoplasmosis: in the storm of the eye. Parasite Immunol 28:635–642

    Article  CAS  PubMed  Google Scholar 

  64. Khairallah M, Yahia SB, Zaouali S et al (2007) Acute choroidal ischemia associated with toxoplasmic retinochoroiditis. Retina 27:947–951

    Article  PubMed  Google Scholar 

  65. Khan IA, Eckel ME, Pfefferkorn ER et al (1988) Production of gamma interferon by cultured human lymphocytes stimulated with a purified membrane protein (P30) from Toxoplasma gondii. J Infect Dis 157:979–984

    Article  CAS  PubMed  Google Scholar 

  66. Kishore K, Conway MD, Peyman GA (2001) Intravitreal clindamycin and dexamethasone for toxoplasmic retinochoroiditis. Ophthalmic Surg Lasers 32:183–192

    CAS  PubMed  Google Scholar 

  67. Kodjikian L, Wallon M, Fleury J et al (2006) Ocular manifestations in congenital toxoplasmosis. Graefes Arch Clin Exp Ophthalmol 244:14–21

    Article  PubMed  Google Scholar 

  68. Koppe JG, Rothova A (1989) Congenital toxoplasmosis. A long-term follow-up of 20 years. Int Ophthalmol 13:387–390

    Article  CAS  PubMed  Google Scholar 

  69. Lang C, Gross U, Luder CG (2007) Subversion of innate and adaptive immune responses by Toxoplasma gondii. Parasitol Res 100:191–203

    Article  PubMed  Google Scholar 

  70. Liesenfeld O, Kosek JC, Suzuki Y (1997) Gamma interferon induces Fas-dependent apoptosis of Peyer’s patch T cells in mice following peroral infection with Toxoplasma gondii. Infect Immun 65:4682–4689

    PubMed Central  CAS  PubMed  Google Scholar 

  71. Liesenfeld O, Montoya JG, Kinney S et al (2001) Effect of testing for IgG avidity in the diagnosis of Toxoplasma gondii infection in pregnant women: experience in a US reference laboratory. J Infect Dis 183:1248–1253

    Article  CAS  PubMed  Google Scholar 

  72. Liesenfeld O, Press C, Montoya JG et al (1997) False-positive results in immunoglobulin M (IgM) toxoplasma antibody tests and importance of confirmatory testing: the Platelia Toxo IgM test. J Clin Microbiol 35:174–178

    PubMed Central  CAS  PubMed  Google Scholar 

  73. Lucena DR, Siqueira RC, Yugar J et al (2001) Vitreoschisis in posterior uveitis: OLYS (Oréfice Lucena Yugar Siqueira) theory of formation and its presentation forms. Rev Bras Oftalmol 60:90–95

    Google Scholar 

  74. Lynch MI, Cordeiro F, Ferreira S et al (2004) Lacrimal secretory IgA in active posterior uveitis induced by Toxoplasma gondii. Mem Inst Oswaldo Cruz 99:861–864

    Article  CAS  PubMed  Google Scholar 

  75. Mack DG, Johnson JJ, Roberts F et al (1999) HLA-class II genes modify outcome of Toxoplasma gondii infection. Int J Parasitol 29:1351–1358

    Article  CAS  PubMed  Google Scholar 

  76. Mahalakshmi B, Therese KL, Madhavan HN et al (2006) Diagnostic value of specific local antibody production and nucleic acid amplification technique-nested polymerase chain reaction (nPCR) in clinically suspected ocular toxoplasmosis. Ocul Immunol Inflamm 14:105–112

    Article  CAS  PubMed  Google Scholar 

  77. McAuley J, Boyer KM, Patel D et al (1994) Early and longitudinal evaluations of treated infants and children and untreated historical patients with congenital toxoplasmosis: the Chicago Collaborative Treatment Trial. Clin Infect Dis 18:38–72

    Article  CAS  PubMed  Google Scholar 

  78. McLeod R, Beem MO, Estes RG (1985) Lymphocyte anergy specific to Toxoplasma gondii antigens in a baby with congenital toxoplasmosis. J Clin Lab Immunol 17:149–153

    CAS  PubMed  Google Scholar 

  79. McLeod R, Boyer K, Karrison T et al (2006) Outcome of treatment for congenital toxoplasmosis, 1981–2004: the National Collaborative Chicago-Based, Congenital Toxoplasmosis Study. Clin Infect Dis 42:1383–1394

    Article  PubMed  Google Scholar 

  80. McMenamin PG, Dutton GN, Hay J et al (1986) The ultrastructural pathology of congenital murine toxoplasmic retinochoroiditis. Part I: the localization and morphology of Toxoplasma cysts in the retina. Exp Eye Res 43:529–543

    Article  CAS  PubMed  Google Scholar 

  81. Meneceur P, Bouldouyre MA, Aubert D et al (2008) Toxoplasma gondii: in vitro susceptibility of various genotypic strains to pyrimethamine, sulfadiazine and atovaquone. Antimicrob Agents Chemother 52:1269–1277

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  82. Mets MB, Holfels E, Boyer KM et al (1997) Eye manifestations of congenital toxoplasmosis. Am J Ophthalmol 123:1–16

    Article  CAS  PubMed  Google Scholar 

  83. Montoya JG (2002) Laboratory diagnosis of Toxoplasma gondii infection and toxoplasmosis. J Infect Dis 185(Suppl 1):S73–S82

    Article  PubMed  Google Scholar 

  84. Montoya JG, Liesenfeld O (2004) Toxoplasmosis. Lancet 363:1965–1976

    Article  CAS  PubMed  Google Scholar 

  85. Montoya JG, Parmley S, Liesenfeld O et al (1999) Use of the polymerase chain reaction for diagnosis of ocular toxoplasmosis. Ophthalmology 106:1554–1563

    Article  CAS  PubMed  Google Scholar 

  86. Montoya JG, Remington JS (1996) Toxoplasmic chorioretinitis in the setting of acute acquired toxoplasmosis. Clin Infect Dis 23:277–282

    Article  CAS  PubMed  Google Scholar 

  87. Moshfeghi DM, Dodds EM, Couto CA et al (2004) Diagnostic approaches to severe, atypical toxoplasmosis mimicking acute retinal necrosis. Ophthalmology 111:716–725

    Article  PubMed  Google Scholar 

  88. Mosmann TR, Cherwinski H, Bond MW et al (1986) Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 136:2348–2357

    CAS  PubMed  Google Scholar 

  89. Nozik RA (1977) Results of treatment of ocular toxoplasmosis with injectable corticosteroids. Trans Sect Ophthalmol Am Acad Ophthalmol Otolaryngol 83:811–818

    CAS  PubMed  Google Scholar 

  90. O’Connor GR, Frenkel JK (1976) Editorial: dangers of steroid treatment in toxoplasmosis. Periocular injections and systemic therapy. Arch Ophthalmol 94:213

    Article  PubMed  Google Scholar 

  91. Oliveira AA, Oréfice F, Nascimento E (1988) The aqueous humor antibodies coefficient: part I. Arq Bras Oftalmol 51:237–238

    Google Scholar 

  92. Oréfice F, Bahia-Oliveira LM (2005) Toxoplasmose. In: Oréfice F (ed) Uveíte clínica e cirúrgica. Cultura Médica, Rio de Janeiro, pp 699–804

    Google Scholar 

  93. Oréfice JL, Costa RA, Campos W et al (2006) Third-generation optical coherence tomography findings in punctate retinal toxoplasmosis. Am J Ophthalmol 142:503–505

    Article  PubMed  Google Scholar 

  94. Oréfice JL, Costa RA, Oréfice F et al (2007) Vitreoretinal morphology in active ocular toxoplasmosis: a prospective study by optical coherence tomography. Br J Ophthalmol 91:773–780

    Article  PubMed Central  PubMed  Google Scholar 

  95. Oréfice F, Tonelli E (1995) Ganglionar acquired toxoplasmosis associated with granulomatous anterior uveitis without retinochoroiditis. Rev Bras Oftalmol 54:899–902

    Google Scholar 

  96. Pavesio CE, Lightman S (1996) Toxoplasma gondii and ocular toxoplasmosis: pathogenesis. Br J Ophthalmol 80:1099–1107

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  97. Petersen E (2007) Toxoplasmosis. Semin Fetal Neonatal Med 12:214–223

    Article  PubMed  Google Scholar 

  98. Petersen E, Liesenfeld O (2007) Clinical disease and diagnostics. In: Weiss LM, Kim K (eds) Toxoplasma gondii – the model apicomplexan: perspectives and methods. Elsevier Academic Press, Amsterdam, pp 81–100

    Chapter  Google Scholar 

  99. Pinon JM, Dumon H, Chemla C et al (2001) Strategy for diagnosis of congenital toxoplasmosis: evaluation of methods comparing mothers and newborns and standard methods for postnatal detection of immunoglobulin G, M, and A antibodies. J Clin Microbiol 39:2267–2271

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  100. Pinon JM, Foudrinier F, Mougeot G et al (1995) Evaluation of risk and diagnostic value of quantitative assays for anti-Toxoplasma gondii immunoglobulin A (IgA), IgE, and IgM and analytical study of specific IgG in immunodeficient patients. J Clin Microbiol 33:878–884

    PubMed Central  CAS  PubMed  Google Scholar 

  101. Remington JS, McLeod R, Thulliez P et al (2001) Toxoplasmosis. In: Remington JS, Klein J (eds) Infectious diseases of the fetus and newborn infant, 5th edn. WB Saunders, Philadelphia, pp 205–346

    Google Scholar 

  102. Robben PM, Mordue DG, Truscott SM et al (2004) Production of IL-12 by macrophages infected with Toxoplasma gondii depends on the parasite genotype. J Immunol 172:3686–3694

    Article  CAS  PubMed  Google Scholar 

  103. Roberts CW, Gazzinelli RT, Khan IA et al (2007) Adaptive immunity and genetics of the host immune response. In: Weiss LM, Kim K (eds) Toxoplasma gondii – the model apicomplexan: perspectives and methods. Elsevier Academic Press, Amsterdam, pp 608–720

    Google Scholar 

  104. Roberts F, McLeod R (1999) Pathogenesis of toxoplasmic retinochoroiditis. Parasitol Today 15:51–57

    Article  CAS  PubMed  Google Scholar 

  105. Rothova A (2003) Ocular manifestations of toxoplasmosis. Curr Opin Ophthalmol 14:384–388

    Article  PubMed  Google Scholar 

  106. Sabates R, Pruett RC, Brockhurst RJ (1981) Fulminant ocular toxoplasmosis. Am J Ophthalmol 92:497–503

    Article  CAS  PubMed  Google Scholar 

  107. Saeij JP, Boyle JP, Boothroyd JC (2005) Differences among the three major strains of Toxoplasma gondii and their specific interactions with the infected host. Trends Parasitol 21:476–481

    Article  PubMed  Google Scholar 

  108. Schaap D, Vermeulen AN, Roberts CW et al (2007) Vaccination against toxoplasmosis: current status and future prospects. In: Weiss LM, Kim K (eds) Toxoplasma gondii – the model apicomplexan: perspectives and methods. Elsevier Academic Press, Amsterdam, pp 721–759

    Chapter  Google Scholar 

  109. Scherrer J, Iliev ME, Halberstadt M et al (2007) Visual function in human ocular toxoplasmosis. Br J Ophthalmol 91:233–236

    Article  PubMed Central  PubMed  Google Scholar 

  110. Schwartz PL (1977) Segmental retinal periarteritis as a complication of toxoplasmosis. Ann Ophthalmol 9:157–162

    CAS  PubMed  Google Scholar 

  111. Silveira C, Belfort R Jr, Burnier M Jr et al (1988) Acquired toxoplasmic infection as the cause of toxoplasmic retinochoroiditis in families. Am J Ophthalmol 106:362–364

    Article  CAS  PubMed  Google Scholar 

  112. Silveira C, Belfort R Jr, Muccioli C et al (2001) A follow-up study of Toxoplasma gondii infection in southern Brazil. Am J Ophthalmol 131:351–354

    Article  CAS  PubMed  Google Scholar 

  113. Silveira C, Belfort R Jr, Muccioli C et al (2002) The effect of long-term intermittent trimethoprim/sulfamethoxazole treatment on recurrences of toxoplasmic retinochoroiditis. Am J Ophthalmol 134:41–46

    Article  CAS  PubMed  Google Scholar 

  114. Smith JR, Cunningham ET Jr (2002) Atypical presentations of ocular toxoplasmosis. Curr Opin Ophthalmol 13:387–392

    Article  PubMed  Google Scholar 

  115. Sobrin L, Kump LI, Foster CS (2007) Intravitreal clindamycin for toxoplasmic retinochoroiditis. Retina 27:952–957

    Article  PubMed  Google Scholar 

  116. Stanford MR, See SE, Jones LV et al (2003) Antibiotics for toxoplasmic retinochoroiditis: an evidence-based systematic review. Ophthalmology 110:926–931; quiz 931–922

    Article  PubMed  Google Scholar 

  117. Stanford MR, Tan HK, Gilbert RE (2006) Toxoplasmic retinochoroiditis presenting in childhood: clinical findings in a UK survey. Br J Ophthalmol 90:1464–1467

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  118. Steahly LP (1988) Endolaser photocoagulation of toxoplasmosis. Ann Ophthalmol 20:463–465

    CAS  PubMed  Google Scholar 

  119. Suzuki Y, Wong SY, Grumet FC et al (1996) Evidence for genetic regulation of susceptibility to toxoplasmic encephalitis in AIDS patients. J Infect Dis 173:265–268

    Article  CAS  PubMed  Google Scholar 

  120. Tenter AM, Heckeroth AR, Weiss LM (2000) Toxoplasma gondii: from animals to humans. Int J Parasitol 30:1217–1258

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  121. Theodossiadis P, Kokolakis S, Ladas I et al (1995) Retinal vascular involvement in acute toxoplasmic retinochoroiditis. Int Ophthalmol 19:19–24

    Article  CAS  PubMed  Google Scholar 

  122. Thiebaut R, Leproust S, Chene G et al (2007) Effectiveness of prenatal treatment for congenital toxoplasmosis: a meta-analysis of individual patients’ data. Lancet 369:115–122

    Article  PubMed  Google Scholar 

  123. Vasconcelos-Santos DV, Azevedo DOM, Campos WR et al (2009) Congenital toxoplasmosis in southeastern Brazil: results of early ophthalmologic examination of a large cohort of neonates. Ophthalmology 116:2199–2205

    Article  PubMed  Google Scholar 

  124. Vasconcelos-Santos DV, Nehemy MB, Rich RM et al (2007) Intravitreal triamcinolone acetonide: potential complications. Expert Rev Ophthalmol 2:987–999

    Article  CAS  Google Scholar 

  125. Vidigal PV, Santos DV, Castro FC et al (2002) Prenatal toxoplasmosis diagnosis from amniotic fluid by PCR. Rev Soc Bras Med Trop 35:1–6

    Article  PubMed  Google Scholar 

  126. Villena I, Aubert D, Brodard V et al (1999) Detection of specific immunoglobulin E during maternal, fetal, and congenital toxoplasmosis. J Clin Microbiol 37:3487–3490

    PubMed Central  CAS  PubMed  Google Scholar 

  127. Wallon M, Kodjikian L, Binquet C et al (2004) Long-term ocular prognosis in 327 children with congenital toxoplasmosis. Pediatrics 113:1567–1572

    Article  PubMed  Google Scholar 

  128. Westfall AC, Lauer AK, Suhler EB et al (2005) Toxoplasmosis retinochoroiditis and elevated intraocular pressure: a retrospective study. J Glaucoma 14:3–10

    Article  PubMed  Google Scholar 

  129. Wilson CB, Remington JS, Stagno S et al (1980) Development of adverse sequelae in children born with subclinical congenital Toxoplasma infection. Pediatrics 66:767–774

    CAS  PubMed  Google Scholar 

  130. Yamamoto JH, Vallochi AL, Silveira C et al (2000) Discrimination between patients with acquired toxoplasmosis and congenital toxoplasmosis on the basis of the immune response to parasite antigens. J Infect Dis 181:2018–2022

    Article  CAS  PubMed  Google Scholar 

  131. Yang P, Das PK, Kijlstra A (2000) Localization and characterization of immunocompetent cells in the human retina. Ocul Immunol Inflamm 8:149–157

    Article  CAS  PubMed  Google Scholar 

  132. Zamora DO, Rosenbaum JT, Smith JR (2008) Invasion of human retinal vascular endothelial cells by Toxoplasma gondii tachyzoites. Br J Ophthalmol 92:852–855

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil

    Fernando Oréfice MD, PhD, Daniel Vítor Vasconcelos-Santos MD, PhD & Juliana Lambert Oréfice MD, PhD

  2. Uveitis Division, Centro Brasileiro de Ciências Visuais, Belo Horizonte, Brazil

    Fernando Oréfice MD, PhD & Daniel Vítor Vasconcelos-Santos MD, PhD

  3. Universidade Federal de São Paulo, São Paulo, Brazil

    Rogério Alves Costa MD, PhD

  4. Retina Division, Hospital de Olhos de Araraquara, Araraquara, SP, Brazil

    Rogério Alves Costa MD, PhD

  5. Macula Division, Centro Brasileiro de Ciências Visuais, Belo Horizonte, Brazil

    Rogério Alves Costa MD, PhD

  6. Imaging Division, Centro Brasileiro de Ciências Visuais, Belo Horizonte, MG, Brazil

    Juliana Lambert Oréfice MD, PhD

Authors
  1. Fernando Oréfice MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Daniel Vítor Vasconcelos-Santos MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Rogério Alves Costa MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Juliana Lambert Oréfice MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Fernando Oréfice MD, PhD .

Editor information

Editors and Affiliations

  1. Centre of Ophthalmology, University of Tuebingen, Tuebingen, Germany

    Manfred Zierhut

  2. Biomedical Research Centre, Institute of Ophthalmology, Moorfields Eyes Hospital, Department of Medical Retina, UCL, London, United Kingdom

    Carlos Pavesio

  3. School of Medicine, Department of Ophthalmology, Hokkaido University Graduate, Sapporo, Hokkaido, Japan

    Shigeaki Ohno

  4. University of Belo Horizonte, Belo Horizonte, Brazil

    Fernando Orefice

  5. USC Eye Institute, University of Southern California, Los Angeles, California, USA

    Narsing A. Rao

1 Electronic Supplementary Material

Below is the link to the electronic supplementary material.

Case Report 88

Toxoplasmosis (PPTX 481 kb)

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Oréfice, F., Vasconcelos-Santos, D.V., Costa, R.A., Oréfice, J.L. (2016). Toxoplasmosis. In: Zierhut, M., Pavesio, C., Ohno, S., Orefice, F., Rao, N. (eds) Intraocular Inflammation. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-75387-2_138

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-75387-2_138

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-75385-8

  • Online ISBN: 978-3-540-75387-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation